Experience

SHEPHERD

• United States
• Biotechnology Research
• 1 - 100 Employee

• Founder and Chief Executive Officer

  • Jan 2016 - 8 years

  Boston, Massachusetts SHEPHERD is a computational oncology company that realizes the promise of multi-omic data to drive drug development and personalized oncology. To learn more, visit shepherd.bio. BioSpace's Top 20 Companies to Watch in 2018 Forbes 30 Under 30 Charles River Research Models in Drug Discovery Award



The Billion Life Project

• Founding Partner

  • Apr 2023 - 9 months

  Defiantly Human. Built To Last. Built To Save. Built To Outlive Us. The mission of The Billion Life Project is to harness capitalism to build self-sustaining solutions to humanity’s greatest needs and suffering. The Billion Life Project is a group of company founders, investors, executives, employees, CEOs, janitors, influencers, artists, designers, parents, patients, doctors, DJs, and human beings committed to collectively help build the organisations that will save a billion… Show more Defiantly Human. Built To Last. Built To Save. Built To Outlive Us. The mission of The Billion Life Project is to harness capitalism to build self-sustaining solutions to humanity’s greatest needs and suffering. The Billion Life Project is a group of company founders, investors, executives, employees, CEOs, janitors, influencers, artists, designers, parents, patients, doctors, DJs, and human beings committed to collectively help build the organisations that will save a billion lives in the next one hundred years. Show less



Rage to LIVE

• United States
• International Affairs

• Founder

  • Apr 2021 - 2 years 9 months

  A brand. A rallying cry. A world. #RTLForever Overcome selfishness, weakness, laziness, and fear to do better, harder things. And die of nothing but a Rage to LIVE.



SHEPHERD Health

• Founder and Chief Executive Officer

  • Jan 2023 - 1 year

  Boston, Massachusetts, United States SHEPHERD is an Unapologetically Human, Defiantly Democratic Personalized Medicine and Digital Healthcare Company. SHEPHERD believes cancer is a mathematics problem. Infinitely complex and unsolvable with traditional science. Which is why single-target based hypotheses have resulted in an overall response rate to “targeted therapies” of 7% in the last 15 years. The reality is that any therapeutic has a full suite of activity across the entire multi-omic profile of a patient. Our answer… Show more SHEPHERD is an Unapologetically Human, Defiantly Democratic Personalized Medicine and Digital Healthcare Company. SHEPHERD believes cancer is a mathematics problem. Infinitely complex and unsolvable with traditional science. Which is why single-target based hypotheses have resulted in an overall response rate to “targeted therapies” of 7% in the last 15 years. The reality is that any therapeutic has a full suite of activity across the entire multi-omic profile of a patient. Our answer is a multi-omic, advanced mathematics platform, called DELVE, which can capture the full biological impact of any drug on any patient. The result? The highest-potential personalized drug recommendations that medicine can offer, delivered digitally direct to patients, enabling defiantly democratic access to world class medicine for any patient anywhere. SHEPHERD also applies the platform to drug development in partnership with biopharma companies across therapeutic modalities including immunotherapies. SHEPHERD identifies the full RNA impact signature of a therapeutic and the full RNA characteristics necessary for it’s maximum therapeutic efficacy and durability - on any patient with any type of cancer at any stage of disease. The result is a pan-indication, patient by patient prediction of whether a therapeutic will work for a specific patient or not and to what degree. SHEPHERD dreams of a world in which every patient, from the hospitals of Brooklyn to the villages of Ethiopia, regardless of race, religion, creed, gender, socioeconomic status, or geographical location is given the optimum care most likely to afford them a fighting chance to LIVE for decades not days. There is ALWAYS Hope. It LIVES at SHEPHERD. Show less



SHEPHERD Foundation

• Non-profit Organizations

• Founder and Executive Chairman

  • Oct 2017 - 6 years 3 months

  Boston, Massachusetts; Washington D.C. The SHEPHERD Foundation is the non-profit arm of SHEPHERD Therapeutics. The Foundation's aim is to support disease-specific research for otherwise neglected forms of rare cancer and to create new disease-specific research foundations around every form of rare cancer - with one goal: to enable the creation of as many life-saving therapeutics as possible for otherwise neglected patients.



Forbes

• United States
• Book and Periodical Publishing
• 700 & Above Employee

• 30 Under 30

  • Jan 2017 - 7 years

  I am incredibly honored and humbled to have made the 2017 Forbes 30 Under 30 list out of over 15,000 nominees. Thank you so much Forbes and to everyone who made this possible. And thank you so much to the SHEPHERD team! I owe this to them. We hope you'll join us in our mission to save the life of every rare cancer patient. www.forbes.com/profile/david-hysong/



The Aspen Institute

• United States
• Non-profit Organizations
• 500 - 600 Employee

• Spotlight Health Scholar

  • Mar 2017 - Mar 2018

  Aspen, CO



Harvard University

• United States
• Higher Education
• 700 & Above Employee

• Seminarian

  • Sep 2013 - May 2015

  The Memorial Church